Arcturus Therapeutics
ARCT
#8484
Rank
ยฃ0.15 B
Marketcap
ยฃ5.41
Share price
-3.36%
Change (1 day)
-63.35%
Change (1 year)

Revenue for Arcturus Therapeutics (ARCT)

Revenue in 2025 (TTM): ยฃ64.83 Million

According to Arcturus Therapeutics 's latest financial reports the company's current revenue (TTM ) is ยฃ64 Million. In 2024 the company made a revenue of ยฃ0.11 Billion a decrease over the revenue in the year 2023 that were of ยฃ0.12 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Arcturus Therapeutics from 2013 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ64.83 M-41.21%
2024 ยฃ0.11 B-10.94%
2023 ยฃ0.12 B-27.2%
2022 ยฃ0.17 B1757.53%
2021 ยฃ9.15 M30.83%
2020 ยฃ6.99 M-55.86%
2019 ยฃ15.85 M27.75%
2018 ยฃ12.41 M-16.37%
2017 ยฃ14.83 M
2016 N/A
2015 N/A
2014 N/A
2013 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
NRC Health
NRC
ยฃ0.10 B 63.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
N/AN/A Bahamas